Novacare Drug Specialities Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 1992.
1992 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Novacare Drug Specialities Private Limited

Novacare Drug Specialities Private Limited, a active private limited company, was established on 25 June 1992 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24239MH1992PTC067417. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.63 M.

Formerly known as Novacare Drug Specialities Limited. It upholds a compliant status. Employing 267 professional, Its leadership includes Ramakrishnan Kannan (Managing Director), Hema Kannan (Director). Past directors included Ramakrishnan Kannan, Lalitha Vasudevan, Ravindran Ramakrishna Panikar. It holds ₹1.72 M open charges and ₹33.58 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 103, A Wing, Orion Business Park,, Chheda Mall, Near Cine Wonder, Ghodbunder Rd,, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1992PTC067417

  • Registration Number

    067417

  • Incorporation Date

    25 June 1992

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹0.63 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 0.63 M
  • Company Age 33 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.72 M
  • Satisfied Charges ₹ 33.58 Cr
  • Revenue Growth **** -71.25%
  • Profit Growth **** -34.97%
  • Ebitda **** 36.29%
  • Net Worth 3.07%
  • Total Assets -5.73%
Company report

Novacare Drug Specialities Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novacare Drug Specialities Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Novacare Drug Specialities Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramakrishnan Kannan Managing Director 25 Jun 1992 Current
Hema Kannan Director 03 Nov 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Feb 2012 Past
Pramod Abcsdd Director 25 Jun 2018 Past
Pramod Abcsdd Director 25 Jun 2018 Past
Pramod Abcsdd Director 25 Jun 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novacare Drug Specialities.

Novacare Drug Specialities Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.25% decrease. The company also saw a substantial fall in profitability, with a 34.97% decrease in profit. The company's net worth moved up by a moderate rise of 3.07%.

Novacare Drug Specialities revenue growth over time
Novacare Drug Specialities profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -71.25%
*******
*******
*******
*******
Revenue from Operations
*******
 -89.27%
*******
*******
*******
*******
Total Assets
*******
 -5.73%
*******
*******
*******
*******
Profit or Loss
*******
 -34.97%
*******
*******
*******
*******
Net Worth
*******
 3.07%
*******
*******
*******
*******
EBITDA
*******
 36.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novacare Drug Specialities?

Unlock access to Novacare Drug Specialities's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,715,000.00

Satisfied Charges

₹335,764,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.13 Cr
  • Hdfc Bank Limited : 0.04 Cr
Latest Charge Details
Date Lender Amount Status
03 May 2017 Hdfc Bank Limited ₹0.44 M Open
13 Nov 2015 Others ₹1.28 M Open
31 Jul 2012 Hdfc Bank Limited ₹5.00 M Satisfied
21 May 2012 Hdfc Bank Limited ₹4.00 M Satisfied
22 May 2005 Hdfc Bank Limited ₹32.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Novacare Drug Specialities?

Novacare Drug Specialities has a workforce of 267 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novacare Drug Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novacare Drug Specialities's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novacare Drug Specialities
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 31 Jul 2012 via Charge ID 10372946 with Hdfc Bank Limited was fully satisfied on 28 Nov 2025. was completed.

  • Charges

    A charge registered on 21 May 2012 via Charge ID 10355588 with Hdfc Bank Limited was fully satisfied on 28 Nov 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Novacare Drug Specialities Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Novacare Drug Specialities Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Charges

    The activity A charge registered on 22 May 2005 via Charge ID 80026350 with Hdfc Bank Limited was fully satisfied on 12 Apr 2019. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 322.50 M registered on 22 May 2005 with Charge ID 80026350 was modified on 17 May 2018. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novacare Drug Specialities Private Limited?

The CIN of Novacare Drug Specialities Private Limited is U24239MH1992PTC067417.

Where is Novacare Drug Specialities Private Limited headquartered?

Novacare Drug Specialities Private Limited is headquartered at Shop No. 103, A Wing, Orion Business Park,, Chheda Mall, Near Cine Wonder, Ghodbunder Rd,, Thane, Maharashtra, 400607.

When was Novacare Drug Specialities Private Limited incorporated?

Novacare Drug Specialities Private Limited was incorporated on 25 June 1992.

Who are the current directors of Novacare Drug Specialities Private Limited?

The current directors of Novacare Drug Specialities Private Limited are

What is the primary industry of Novacare Drug Specialities Private Limited?

The primary industry of Novacare Drug Specialities Private Limited is Manufacturing.

Is Novacare Drug Specialities Private Limited a listed company?

Novacare Drug Specialities Private Limited is unlisted.

What is the capital structure of Novacare Drug Specialities Private Limited?

The authorized capital of Novacare Drug Specialities Private Limited is ₹2.00 M, and the paid-up capital is ₹0.63 M.

What is the compliance status of Novacare Drug Specialities Private Limited?

The compliance status of Novacare Drug Specialities Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available